2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow BRAF Gene Mutation: new trials by email Literature Review of BRAF Gene Mutation trials Research Report on BRAF Gene Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continued Access to RXDX-105 RXDX-105 - Non Small Cell Lung Cancer, Ovarian Cancer | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 3 | 2018-12-14 | 2025-05-15 |
| Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations Crizotinib, Laboratory Biomarker Analysis, Pharmacological Study - Advanced Malignant Neoplasm, BRAF Gene Mutation | Phase 1 | Completed | M.D. Anderson Cancer Center | 46 | 2012-02-06 | 2021-01-22 |
Carcinoma, Non-Small-Cell Lung (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Recurrence (1)
Adnexal Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Disease Attributes (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1)
Crizotinib (1) · Sorafenib (1) · Vemurafenib (1) · agerafenib (1)
M.D. Anderson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1)
United States (2)
Alexander Drilon, MD (1) · Filip Janku (1)
P30CA016672 (1)